HOSHI IRYO-SANKI CO., LTD.
株式会社星医療酸器
Valuation
Fundamental ratios for the latest reported period.
Ticker: 7634
FY2025 (Mar 2026) · J-GAAP · consolidated Source: filing S100YHH0
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 49.5% |
|---|---|
| Operating margin | 12.4% |
| Net margin | 8.8% |
| Return on equity | 7.1%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 5.3% |
| Revenue growth (YoY) | 2.8% |
| EPS (basic) | ¥439.59 |
| EPS growth (YoY) | -6.3% |
| Current ratio | 3.17x |
| Equity ratio | 74.8% |
| Book value / share | ¥6,401.95 |
| Free cash flow | ¥2.1B |